Anticoagulation before urgent surgery — MCCQE Part 1 MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Withhold apixaban and activate a coordinated urgent-surgery plan
Apixaban should be withheld and orthopedics, anesthesia, and thrombosis or hematology should coordinate an urgent plan using the last dose, kidney function, operative and neuraxial bleeding risk, and the harm of delaying hip-fracture repair. A fixed elective interruption table cannot be applied blindly to an urgent fracture, and local access to calibrated anti-Xa testing or reversal may affect exceptional cases. Vitamin K reverses warfarin, not apixaban. Routine therapeutic heparin bridging is unnecessary because DOACs have rapid offset and onset and bridging increases bleeding. Proceeding eight hours after a dose without anesthetic review may be unsafe, especially if neuraxial anesthesia is contemplated. Conversely, a universal two-week delay exposes the patient to immobility, delirium, and other complications. Postoperative prophylaxis and resumption are individualized after hemostasis.
Reference: Thrombosis Canada, DOACs: Perioperative Management: https://thrombosiscanada.ca/hcp/practice/clinical_guides?guideID=PERIOPERATIVEMANAGEMENTOFPATIE&language=en-ca